Trim IBM ~25% to Underweight; sell covered calls at $245-$250 vs residual for income
The conservative analyst wins the structural argument; the neutral analyst's framing deserves serious consideration on sizing but its execution details violate prior lessons; the aggressive analyst commits precisely the errors the prior decision log has repeatedly flagged. Passive Hold at full benchmark weight has produced negative alpha through drift erosion in this compression-below-declining-MAs setup. Technical structure is unambiguously damaged with price $14 below declining 50 SMA ($245.93) and $31 below declining 200 SMA ($262.34); both slopes negative. Volume profile confirms distribution with three failed $238 attempts and 83% volume collapse. Fundamentals deteriorating structurally: revenue growth decelerated from +7.6% (FY25) to +1.1% (Q2 2026), operating income contracted -7.7% YoY. However, defensive ballast is quantitative: 5.5% FCF yield, 2.87% dividend covered 1.9x, beta 0.705, 20+ year dividend track record. Risk/reward is more balanced than pure bear framing: downside to $204 is ~12%, upside to $262 reclaim is ~13.5%. Q3 2026 earnings is a binary catalyst where beat-and-raise with HashiCorp disclosure could produce 8-15% gap-up.
| Position | Action |
|---|---|
| Current position | Trim ~25% immediately at market |
| Residual position after trim | Retain ~75% core position sized to dividend/FCF stream |
| Residual position invalidation | Hard stop at $204 (July 22 swing low, ~1.5x compressed ATR) |
| New capital | No fresh initiation |
| Residual long exposure | Sell covered calls at $245-$250 strike for October expiry (est. 1.5-2.5% premium) |
IBM is a cash-rich, low-beta enterprise with inflecting momentum, supportive macro conditions, and strong fundamentals that the bear is misreading through lagging technical indicators rather than leading signals.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $262.02 | bearish |
| 50 SMA | $245.09 | bearish |
| 10 EMA | $233.38 | neutral |
| RSI (14) | 46.51 | neutral |
| RSI Low (7/22) | 29.82 | bullish |
| RSI Recovery High (8/11) | 51.74 | bullish |
| MACD | -1.56 | bullish |
| MACD Signal | -2.85 | bullish |
| MACD Histogram | +1.28 | bullish |
| MACD Histogram Streak | 18 consecutive sessions | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 2026 beat-and-raise with HashiCorp contribution disclosure and no goodwill impairment discussion
Then: Upgrade to Overweight
EV: $245 → $252 → $262 (6–14% gain on 3–6 month horizon); 2:1 to 3:1 risk/reward · concedes: Tactical/swing traders: HOLD warranted for 2-week horizon awaiting $238.50 confirmation breakout
IBM's "coiled spring" is a loaded trap with downside bias—the stock is a defensive yield trade, not a growth investment, with bearish technical structure, deteriorating fundamentals, and active relative-value rotation away from the name.
· concedes: Low beta (0.705) works in IBM's favor during volatility spikes — it does provide downside floor in a crash; The 2.87% dividend is a valid reason to hold for yield-focused investors; Management defending margin and FCF commitments shows some operational discipline; Revenue guidance cuts and management defending only the floor is at least transparent
→ vs conservative: A 30% gap-down on record volume does not constitute a permanent regime change when stock has stabilized in $204-$238 range for over a month and is consolidating above Bollinger lower band at $220
→ vs conservative: Calling IBM structurally broken due to negative tangible book and sub-1 current ratio ignores $12B FCF, 5.5% FCF yield, and dividend coverage of 2x; negative tangible book reflects $170B treasury stock from buybacks, not operational weakness
→ vs neutral: Waiting for confirmation at $238.50 or pullback to $220 creates circular logic: cannot simultaneously argue trend is broken while demanding a breakout above the level that would confirm reversal
→ vs neutral: Probability of retest to $220 is declining with every session that passes without a breakdown; by the time confirmation is received, entry will be at $240 or higher
| Bollinger Middle (20 SMA) |
| $231.70 |
| neutral |
| Bollinger Upper Band | $242.57 | neutral |
| Bollinger Lower Band | $220.84 | neutral |
| ATR | $7.86 | neutral |
| ATR Peak (7/14) | $16.75 | bearish |
Support: 238.42 · 231.7 · 220.84 · 204.3 · 197.77 | Resistance: 238.42 · 242.57 · 245.09 · 252.43 · 262.02
IBM is in a post-shock consolidation phase following a catastrophic gap-down on July 14, 2026 (close $215.52, down ~30% from $288.16 on volume of ~67.4M shares). Price has stabilized in a $204–$238 range with volatility compressed (ATR $7.86 vs. $16.75 peak). Short-term momentum indicators (MACD histogram positive 18 sessions, RSI recovered from 29.82 to 46.51) are constructive but price remains ~12% below the 200 SMA and ~6% below the 50 SMA, both declining — confirming the broader bearish trend. A breakout above $238.50 with volume would shift the recommendation to BUY; a breakdown below $220 would trigger SELL/REDUCE. Final recommendation: HOLD for existing positions; WAIT for new entries.
Market Cap
$217.7B
PE (TTM)
20.5x
Forward PE
17.6x
PEG Ratio
2.41
Price/Book
6.32x
EV/EBITDA
~16.5x
Dividend Yield
2.87%
FCF Yield (TTM)
~5.5%
Tangible Book Value
-$54.1B
Annual Revenue 2021
$60.5B
Annual Revenue 2022
$60.5B
Annual Revenue 2023
$61.9B
Annual Revenue 2024
$62.8B
Annual Revenue 2025
$67.5B
Diluted EPS 2021
$1.80
Diluted EPS 2022
$1.80
Diluted EPS 2023
$8.14
Diluted EPS 2024
$6.43
Diluted EPS 2025
$11.17
Diluted EPS TTM
$11.27
Forward EPS
$13.16
Net Income 2025
$10.6B
Net Income TTM
$10.7B
Net Margin TTM
15.5%
Operating Margin TTM
16.5%
ROE TTM
34.5%
ROA TTM
5.3%
Revenue TTM
$69.1B
Gross Profit TTM
$40.1B
EBITDA TTM
$16.5B
Operating Income 2025
$12.5B
Q2 2026 Revenue
$17.16B
Q2 2026 Gross Margin
57.7%
Q2 2026 Operating Margin
16.6%
Q2 2026 Net Income
$2.17B
Q2 2026 Diluted EPS
$2.27
Q1 2026 Revenue
$15.92B
Q1 2026 Operating Margin
13.9%
Q1 2026 Net Income
$1.22B
Q1 2026 Diluted EPS
$1.28
Q4 2025 Revenue
$19.69B
Q4 2025 Gross Margin
60.6%
Q4 2025 Operating Margin
24.6%
Q4 2025 Net Income
$5.60B
Q4 2025 Diluted EPS
$5.88
Q3 2025 Revenue
$16.33B
Q3 2025 Gross Margin
57.3%
Q3 2025 Operating Margin
17.1%
Q3 2025 Net Income
$1.74B
Q3 2025 Diluted EPS
$1.84
Q2 2025 Revenue
$16.98B
Q2 2025 Gross Margin
58.8%
Q2 2025 Operating Margin
18.2%
Q2 2025 Net Income
$2.19B
Q2 2025 Diluted EPS
$2.31
Annual FCF 2022
$8.5B
Annual FCF 2023
$12.1B
Annual FCF 2024
$11.8B
Annual FCF 2025
$11.5B
TTM Free Cash Flow
$12.05B
Annual Operating CF 2022
$10.4B
Annual Operating CF 2023
$13.9B
Annual Operating CF 2024
$13.4B
Annual Operating CF 2025
$13.2B
Annual CapEx 2022
$1.97B
Annual CapEx 2023
$1.81B
Annual CapEx 2024
$1.69B
Annual CapEx 2025
$1.74B
Annual Dividends 2022
$5.95B
Annual Dividends 2023
$6.04B
Annual Dividends 2024
$6.15B
Annual Dividends 2025
$6.26B
Q2 2026 FCF
$2.21B
Q2 2026 Dividends
$1.59B
Q1 2026 FCF
$4.78B
Q1 2026 Dividends
$1.58B
Annualized Dividend
~$6.5B
Quarterly Dividend Rate
$1.59–$1.71
Total Assets Q2 2026
$152.1B
Total Liabilities Q2 2026
$117.6B
Stockholders' Equity Q2 2026
$34.5B
Stockholders' Equity Q1 2026
$33.0B
Total Debt Q2 2026
$65.3B
Total Debt Q1 2026
$69.8B
Cash & Equivalents Q2 2026
$7.2B
Cash & Equivalents Q1 2026
$10.8B
Net Debt Q2 2026
$54.8B
Goodwill & Intangibles Q2 2026
$88.6B
Working Capital Q2 2026
-$7.5B
Current Ratio Q2 2026
0.79
Debt/Equity Ratio
189%
Interest Coverage (EBITDA/Interest)
~8.5x
Treasury Stock
$170.9B
Pension Obligations
$10.8B
Q2 2026 Debt Paydown
$4.2B
Q2 2026 Share Repurchases
~$115M
HashiCorp Acquisition Cost
$6.4B
52-Week High
$332.46
52-Week Low
$199.19
50-Day Moving Average
$247.36
200-Day Moving Average
$266.00
Beta
0.705
Current Price Approx
~$231
Shares Outstanding
~942M
FX Revenue Exposure
~60%
Goodwill as % of Assets
~49%
Strengths
Concerns
IBM presents as a financially healthy, cash-generative technology stalwart with $12B+ TTM FCF and a 2.87% dividend yield (well-covered at >2x by operating cash flow), trading at a reasonable 17.6x forward PE with ~17% expected EPS growth. The company demonstrated strong operating leverage (operating income grew 52% from 2021–2025 while revenue only rose 12%) and is actively deleveraging following the $6.4B HashiCorp acquisition, reducing debt by $4.2B in Q2 2026. Key risks include elevated goodwill/intangibles ($88.6B), negative tangible book value, tight liquidity (current ratio 0.79), and mid-single-digit revenue growth that may lag hyperscalers in the AI era, though the defensive beta (0.71) and strong FCF yield (~5.5%) provide downside protection for income-oriented investors.
Macro: Fed on hold with 86% probability of zero cuts in 2026 (up 1.2pp hardening hawkish view); US recession priced at 8% (very low), UK at 12%, Japan at 22% (down 32pp WoW). Soft landing base case. Commodities bid: Gold $4,640.80 (+0.36%), Silver +18% MoM, copper firm. Software Q2 revenue & EPS beat rates accelerating sequentially per RBC. A "higher-for-longer / no-landing" regime — structurally bullish for IT services with capex-light, cash-return profiles like IBM.